BEAM Latest Headlines

Cathie Wood's weekly update: buys Broadcom, AMD; sells Tesla, Illumina

at seekingalpha.com (Mon, 19-Jan 7:35 AM)

Beam Therapeutics: De-Risked Late-Stage Pipeline, Clear FDA Pathways, and Strong Cash Runway Underscore Buy Rating and $80 Target

at www.tipranks.com (Wed, 14-Jan 12:07 PM)

Evercore ISI Remains a Buy on Beam Therapeutics (BEAM)

at www.tipranks.com (Wed, 14-Jan 8:28 AM)

Bernstein Keeps Their Buy Rating on Beam Therapeutics (BEAM)

at www.tipranks.com (Wed, 14-Jan 2:36 AM)

Beam Therapeutics Extends Cash Runway to 2029 as FDA Clears Accelerated Path for Lead Gene-Editing Therapies

Market Chameleon (Mon, 12-Jan 11:15 AM)

BEAM Secures FDA Support and Extends Cash Runway to 2029: Key Milestones Elevate Genetic Medicine Ambitions

Market Chameleon (Mon, 12-Jan 7:54 AM)